세계의 감염 예방 시장 보고서(2025년)
Infection Prevention Global Market Report 2025
상품코드 : 1825420
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,493,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,386,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,279,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

감염 예방 시장 규모는 향후 수년간 안정된 성장이 전망됩니다. 2029년에는 CAGR 3.7%로 519억 1,000만 달러로 성장합니다. 예측 기간의 성장은 신흥 감염병, 기술 혁신, 전 세계 인구 증가, 외래 의료 서비스 증가에 기인합니다. 예측 기간의 주요 동향으로는 원격의료 및 디지털 헬스 솔루션, 개인 맞춤형 감염 예방, 인공지능(AI) 활용 확대, 신속한 진단, 행동 중재에 대한 집중 등을 꼽을 수 있습니다.

향후 5년간 3.7%의 성장률 전망은 지난번 전망치보다 0.2% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 무역 마찰은 프랑스와 브라질에서 개발된 일회용 멸균 장벽과 클로르헥시딘 용액의 가격을 급등시켜 수술 부위 감염률 상승과 수술 후 관리 비용 증가를 가져와 미국의 병원 안전 대책에 지장을 초래할 수 있습니다. 또한 상호 관세와 무역 마찰 및 제한 강화로 인한 세계 경제 및 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.

병원내 감염(HAI) 발생률 증가는 향후 감염 예방 시장의 성장을 가속할 것으로 예측됩니다. HAI는 환자가 병원이나 기타 의료시설에서 의료 치료를 받는 동안 감염되는 것을 말합니다. 감염 예방 전략은 감염 위험을 최소화하고 환자의 안전성을 높이기 위해 고안된 조치를 시행함으로써 이러한 감염에 대처하는 데 있으며, 매우 중요합니다. 예를 들어 스웨덴에 본부를 둔 정부 기관인 유럽질병예방통제센터(ECDC)에 따르면 2022-2023년 실시된 제3차 HAI 유병률 조사(PPS) 데이터에 따르면 EU/EEA의 병원에서 매년 약 430만 명의 환자가 적어도 한 번 이상 HAI에 감염된 것으로 추산됩니다. 있는 것으로 나타났습니다. HAI 발생률이 지속적으로 증가함에 따라 감염 예방 솔루션에 대한 수요가 시장 성장을 주도하고 있습니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세 및 Covid와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 대기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 합병과 인수

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KSA
영문 목차

영문목차

Infection prevention encompasses a range of measures and practices aimed at reducing the risk and spread of infectious diseases. These practices include hygiene measures such as regular hand washing, vaccination, and the use of protective equipment. They play a critical role in healthcare settings, public spaces, and personal care to safeguard both individual and public health.

The key product categories within infection prevention include sterilization equipment, disinfectors, and consumables. Sterilization equipment is used to eliminate all forms of microbial life, including bacteria, viruses, and spores, from surfaces, fluids, medications, or biological culture media. Various types of infections, including microbial and healthcare-associated infections, are targeted by these products. They are utilized by a range of end-users such as hospitals and clinics, pharmaceutical companies, clinical laboratories, medical device companies, the life science industry, and academic and research centers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The infection prevention market research report is one of a series of new reports from The Business Research Company that provides infection prevention market statistics, including infection prevention industry global market size, regional shares, competitors with an infection prevention market share, detailed infection prevention market segments, market trends, and opportunities, and any further data you may need to thrive in the infection prevention industry. This infection prevention market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The infection prevention market size has grown steadily in recent years. It will grow from $43.4 billion in 2024 to $44.87 billion in 2025 at a compound annual growth rate (CAGR) of 3.4%. The growth in the historic period can be attributed to increasing awareness of healthcare-associated infections (HAIS), stringent regulatory guidelines, advancements in technology, globalization and international travel, and rising healthcare expenditure.

The infection prevention market size is expected to see steady growth in the next few years. It will grow to $51.91 billion in 2029 at a compound annual growth rate (CAGR) of 3.7%. The growth in the forecast period can be attributed to emerging infectious diseases, technological innovations, global population growth, and rise in ambulatory care services. Major trends in the forecast period include telemedicine and digital health solutions, personalized infection prevention, increased use of artificial intelligence (AI), rapid diagnostics, and focus on behavioral interventions.

The forecast of 3.7% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. hospital safety measures by inflating prices of single-use sterile barriers and chlorhexidine solutions developed in France and Brazil, resulting in higher surgical site infection rates and increased post-operative care costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increase in the incidence of hospital-acquired infections (HAIs) is expected to fuel the growth of the infection prevention market going forward. HAIs refer to infections that patients acquire while receiving healthcare treatment in a hospital or other healthcare facility. Infection prevention strategies are crucial in addressing these infections by implementing measures designed to minimize the risk of infections and enhance patient safety. For instance, according to the European Centre for Disease Prevention and Control (ECDC), a Sweden-based government agency, data from the third Point Prevalence Survey (PPS) of HAIs in 2022-2023 revealed that an estimated 4.3 million patients in EU/EEA hospitals acquire at least one HAI each year. As the incidence of HAIs continues to rise, the demand for infection prevention solutions is driving market growth.

Key players in the infection prevention market are innovating by developing new products such as infection preventionist staffing calculators to enhance their service offerings. These calculators help estimate the required number of infection preventionists in a healthcare facility based on factors such as bed count, patient acuity, and facility type. For example, the Association for Professionals in Infection Control and Epidemiology (APIC) launched an infection preventionist staffing calculator in December 2023. This tool aids hospitals and clinics in determining the appropriate number of infection preventionists (IPs) needed, thereby improving patient safety through optimal staffing levels. Continuous refinement of the calculator using data from healthcare facilities ensures accurate staffing recommendations.

In January 2023, Applied UV, Inc., a US-based disinfection technology company, acquired Puro Lighting for an undisclosed amount. This acquisition allows Applied UV to leverage Puro Lighting's established commercial relationships, including partnerships with major companies such as Acuity Brands, Ushio, and Johnson Controls. Puro Lighting, a US-based medical equipment manufacturing company, specializes in UV light disinfection technologies. This strategic acquisition strengthens Applied UV's position in the disinfection market, particularly in healthcare and commercial applications, enhancing its capabilities in advanced disinfection solutions.

Major companies operating in the infection prevention market report are Cardinal Health Inc., 3M Company, Stryker Corporation, Reckitt Benckiser Group plc, Ecolab Inc., B. Braun Melsungen AG, The Clorox Company, Olympus Corporation, Fortive Corporation, Steris PLC, Genitge AB, Sotera Health Inc., Belimed AG, Coltene Group, Steelco S.p.A., Skytron LLC, Melag Medizintechnik GmbH & Co. KG, Metrex Research, Pal International, Cisa Production S.r.l. Unipersonale, Covalon Technologies Ltd., Biosafe Systems LLC, Terragene SA, Micro-Scientific LLC, Matachana SA

North America was the largest region in the infection prevention market in 2024. The regions covered in the infection prevention market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the infection prevention market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The infection prevention market consists of revenues earned by entities by providing services such as disinfection, sterilization, and isolation precautions. The market value includes the value of related goods sold by the service provider or included within the service offering. The infection prevention market consists of sales of hand hygiene products, personal protective equipment (PPE), antimicrobial wipes and sprays, sharps disposal containers, and biohazard bags. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Infection Prevention Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on infection prevention market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for infection prevention ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The infection prevention market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Infection Prevention Market Characteristics

3. Infection Prevention Market Trends And Strategies

4. Infection Prevention Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Infection Prevention Growth Analysis And Strategic Analysis Framework

6. Infection Prevention Market Segmentation

7. Infection Prevention Market Regional And Country Analysis

8. Asia-Pacific Infection Prevention Market

9. China Infection Prevention Market

10. India Infection Prevention Market

11. Japan Infection Prevention Market

12. Australia Infection Prevention Market

13. Indonesia Infection Prevention Market

14. South Korea Infection Prevention Market

15. Western Europe Infection Prevention Market

16. UK Infection Prevention Market

17. Germany Infection Prevention Market

18. France Infection Prevention Market

19. Italy Infection Prevention Market

20. Spain Infection Prevention Market

21. Eastern Europe Infection Prevention Market

22. Russia Infection Prevention Market

23. North America Infection Prevention Market

24. USA Infection Prevention Market

25. Canada Infection Prevention Market

26. South America Infection Prevention Market

27. Brazil Infection Prevention Market

28. Middle East Infection Prevention Market

29. Africa Infection Prevention Market

30. Infection Prevention Market Competitive Landscape And Company Profiles

31. Infection Prevention Market Other Major And Innovative Companies

32. Global Infection Prevention Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Infection Prevention Market

34. Recent Developments In The Infection Prevention Market

35. Infection Prevention Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기